Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy
2020 ◽
Vol 23
(4)
◽
pp. 330-346
◽
2014 ◽
Vol 13
(2)
◽
pp. e65-e71
◽